Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 264 Glioma 109 Brain Neoplasms 104 Gliosarcoma 85 Central Nervous System Neoplasms 64 Astrocytoma 61 Melanoma 46 Oligodendroglioma 44 Neuroblastoma 28 Recurrence 22 Neoplasm Metastasis 18 Neoplasms 16 Medulloblastoma 16 Ependymoma 16 Sarcoma, Ewing 13 Lymphoma 13 Sarcoma 12 Rhabdomyosarcoma 11 Neuroendocrine Tumors 11 Lung Neoplasms 11 Diffuse Intrinsic Pontine Glioma 10 Small Cell Lung Carcinoma 9 Neuroectodermal Tumors, Primitive 7 Colorectal Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Osteosarcoma 6 Pinealoma 5 Optic Nerve Glioma 5 Choroid Plexus Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5

Interventions

Oxaliplatin 112 Fluorouracil 104 Leucovorin 91 Irinotecan 91 Capecitabine 59 Bevacizumab 58 Cetuximab 46 Folfox protocol 28 Colonoscopy 24 Panitumumab 19 Chemotherapy, Adjuvant 19 Blood Specimen Collection 19 Drug Therapy 18 Nivolumab 17 Magnetic Resonance Spectroscopy 17 Radiotherapy 16 Exercise 16 Early Intervention, Educational 16 Surveys and Questionnaires 15 Laparoscopy 15 Surgical Procedures, Operative 13 Floxuridine 13 Biopsy 13 trifluridine tipiracil drug combination 12 pembrolizumab 12 XELOX 12 Neoadjuvant Therapy 11 Methods 11 Immunohistochemistry 11 Celecoxib 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colonic Neoplasms × Temozolomide × Clear all

NCT06490536 2025-08-29

The Sagittarius Trial

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡